+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy Drug"

From
Epilepsy Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Epilepsy Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Epilepsy Therapeutic Market in APAC 2024-2028 - Product Thumbnail Image

Epilepsy Therapeutic Market in APAC 2024-2028

  • Report
  • January 2024
  • 156 Pages
  • Asia Pacific
From
Pregabalin Market 2022-2026 - Product Thumbnail Image

Pregabalin Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
From
From
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
US Epilepsy Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Epilepsy Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Loading Indicator

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates. Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more